- Original Article
- Published:
Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors
Environmental Health and Preventive Medicine volume 9, pages 243–250 (2004)
Abstract
Objective
The effects of alcohol consumption on coronary risk factors (CRFs) and insulin resistance (IR) have seemed equivocal in previous studies. This study aimed to clarify the implications of low fasting blood insulin observed in alcohol consumers as related to CRFs and IR.
Methods
A cross-sectional observation in 2133 middle-aged healthy Japanese men for associations of increases in alcohol consumption, fasting serum insulin concentration and serum gammaglutamyltransferase (GGT) activity with the major CRFs of high systolic blood pressure (SBP), fasting serum glucose, triglycerides (TG), total- and LDL-cholesterol (tCh&LDLc) and low serum HDL-cholesterol (HDLc).
Results
Increased alcohol consumption was related to higher SBP, serum GGT, glucose and HDLc, and lower serum LDLc and insulin. Although high serum insulin was significantly related to all of the CRFs in all nondrinkers, moderate drinkers consuming up to 59 ml of alcohol per day and excessive drinkers consuming more, the means of SBP, serum glucose and HDLc were significantly higher and serum LDLc was lower in drinkers than in nondrinkers at any level of serum insulin, indicating that the good and bad profiles of CRFs in alcohol consumers are independent of their low fasting serum insulin. High serum GGT related to increased alcohol consumption and/or body weight was significantly associated with high serum insulin and all of the CRFs in all categories of alcohol consumption.
Conclusions
Low fasting serum insulin observed in drinkers does not imply improved CRFs, and thus may not imply improved IR. High serum GGT may reflect increased IR in both drinkers and nondrinkers.
References
Colditz GA, Branch LG, Lipnick RJ, et al. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J. 1985;109:886–889.
Dyer AR, Stamler J, Paul O, et al. Alcohol consumption and 17-year mortality in the Chicago Western Electronic Company Study. Prev Med. 1980;9:78–90.
Marmot MG, Rose G, Shipley MJ, Thomas BJ. Alcohol and mortality: A U-shaped curve. Lancet. 1981;1:580–583.
Nakanishi N, Suzuki K, Tatara K. Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2003; 26:48–54.
Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG, Prospective study of risk factors for development of non-insulin dependent diabetes in middleaged British men. Brit J Med. 1995;310:560–564.
Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Brit J Med. 1995;310:555–559.
Tsumura K, Endo G, Hayashi T, Fujii S, Suematsu C, Okada K. Daily alcohol consumption and the risk of type 2 diabetes in Japanese men. The Osaka Study. Diabetes Care. 1999;22: 1432–1437.
Wei M, Kampert JB, Gibbons LW, Blair SN, Mitchell TL. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care. 2000;23:18–22.
Dixon JB, Dixon ME, O’Brien PE. Alcohol consumption in the severely obese: relationship with the metabolic syndrome. Obes Res. 2002;10:245–252.
Rosell M, De Faire U, Hellenius ML. Low prevalence of the metabolic syndrome in wine drinkers—is it the alcohol beverage or the lifestyle? Eur J Clin Nutr. 2003;57:227–234.
Lee DH, Ha MH, Kim JR, GrossM, Jacobs DR. Gammaglutamyltransferase, alcohol, and blood pressure: a four year follow-up study. Ann Epidemiol. 2002;12:90–96.
Miura K, Nakagawa H, Nakamura H, et al.. Serum gammaglutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens. 1994;8:445–459.
Yamada Y, Ishizaki M, Kido T, et al. Alchol, high blood pressure, and serum γ-glutamyl transpeptidase level. Hypertension. 1991;18:819–826.
Lee DH, Ha MH, Kim JH, et al. Gamma-glutamyltransferase and diabetes—a 4 year follow-up study. Diabetol. 2003;46:359–364.
Nakanishi N, Nishina K, Li W Sato M, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med. 2003;254:287–295.
Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998;21:732–237.
Hashimoto Y, Futamura A, Nakarai H, Nakahara K. Relationship between response of γ-glutamyl transpeptidase to alcohol drinking and risk factors for coronary heart disease. Atherosclerosis. 2001;158:465–470.
Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248:230–238.
Yamada Y, Noborisaka Y, Suzuki H, Ishizaki M, Yamada S. Alcohol consumption, serum gamma-glutamyltransferase levels, and coronary risk factors in a middle-aged occupational population. J Occup Health. 2003;45:293–299.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetol. 1985;28:412–419.
Kiechl S, Willeit J, Poewe W, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Brit Med J. 1996; 313:1040–1041.
Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels. The Normative Aging Study. Am J Epidemiol. 1997; 145:909–916.
Mayer EJ, Newman B, Quesenberry CP, Friedman G, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in association of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 1993; 88[part 1]:2190–2197.
Razzay G, Heaton KW. Moderate alcohol consumption has been shown previously to improve insulin sensitivity in men. Brit J Med. 1997;314:443–444.
Yamada Y Noborisaka Y, Ishizaki M, Tsuritani I, Honda R, Yamada S. Alcohol consumption, homeostasis model assessment indices and blood pressure in middle-aged healthy men. J Hum Hypertens. 2004;18:343–350.
Friedewald WT. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499–509.
Cubeddu LX, Hoffman IS. Insulin resistance and uppernormal glucose levels in hypertension: a review. J Hum Hypertens 2002;16(Suppl 1):S52-S55.
Lu W, Jablonski KA, Resnick HE, et al. Alcohol intake and glycemia in American Indians: The Strong Heart Study. Metabolism. 2003;52:129–135.
Dorn JM Hovey K, Muti P, et al. Alcohol drinking patterns differentially affect central adiposity as measured by abdominal height in women and men. J Nutr. 2003;133:2655–2662.
Mayes PA. Gluconeogenesis and control of the blood glucose. In: Murray RK, Granner DK, Mayes PA, Rodwell VW eds. Harper’s Biochemistry 25th ed. New York: McGraw-Hill, 2000;208–218.
den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romjin JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Artherioscler Thromb Vasc Biol. 2004;24:644–649.
Saglam K, Kilic R, Yilmaz MI, Gulee M, Baykal Y, Kutlu M. Insulin resistance in patients with steatohepatitis. Hepatogastroenterology. 2003;50:456–459.
Arima H, Kiyohara Y, Kato I, et al. Alcohol reduces insulinhypertension relationship in a general population. The Hisayama study. J Clin Epidemiol. 2002;55:863–869.
Bell DSH. Alcohol and the NIDDM patient. Diabetes Care. 1996;19:509–513.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamada, Y., Noborisaka, Y., Ishizaki, M. et al. Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors. Environ Health Prev Med 9, 243–250 (2004). https://doi.org/10.1007/BF02898137
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02898137